ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 251 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $48,515,000 | +24.1% | 522,000 | -20.5% | 0.24% | +33.0% |
| Q3 2021 | $39,097,000 | -32.6% | 656,548 | -22.8% | 0.18% | -23.2% |
| Q2 2021 | $57,970,000 | -1.7% | 850,000 | 0.0% | 0.24% | -19.1% |
| Q1 2021 | $58,982,000 | +2.4% | 850,000 | +13.3% | 0.29% | -15.6% |
| Q4 2020 | $57,623,000 | +22.3% | 750,000 | +19.1% | 0.35% | +6.4% |
| Q3 2020 | $47,109,000 | -16.8% | 629,886 | -30.0% | 0.33% | -28.0% |
| Q2 2020 | $56,655,000 | – | 900,000 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 252,500 | $11,320,000 | 4.95% |
| Rubric Capital Management LP | 857,103 | $38,424,000 | 3.59% |
| PFM Health Sciences, LP | 3,255,230 | $145,932,000 | 3.22% |
| Partner Investment Management, L.P. | 40,605 | $1,820,000 | 2.10% |
| DAFNA Capital Management LLC | 93,942 | $4,211,000 | 1.82% |
| Atika Capital Management LLC | 195,000 | $8,742,000 | 1.78% |
| Perceptive Advisors | 1,400,171 | $62,770,000 | 1.77% |
| EMORY UNIVERSITY | 47,779 | $2,142,000 | 1.51% |
| Rhenman & Partners Asset Management AB | 234,558 | $10,515,000 | 1.23% |
| Eversept Partners, LP | 75,721 | $3,394,572 | 0.99% |